Polyclonal HER2-specific antibodies induced by vaccination mediate receptor internalization and degradation in tumor cells

INTRODUCTION: Sustained HER2 signaling at the cell surface is an oncogenic mechanism in a significant proportion of breast cancers. While clinically effective therapies targeting HER2 such as mAbs and tyrosine kinase inhibitors exist, tumors overexpressing HER2 eventually progress despite treatment....

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Xiu-Rong, Wei, Junping, Lei, Gangjun, Wang, Jiangbo, Lu, Jiuyi, Xia, Wenle, Spector, Neil, Barak, Larry S, Clay, Timothy M, Osada, Takuya, Hamilton, Erika, Blackwell, Kimberly, Hobeika, Amy C, Morse, Michael A, Lyerly, H Kim, Chen, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446352/
https://www.ncbi.nlm.nih.gov/pubmed/22676470
http://dx.doi.org/10.1186/bcr3204

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446352/
https://www.ncbi.nlm.nih.gov/pubmed/22676470
http://dx.doi.org/10.1186/bcr3204

Ejemplares similares